GREEN DAVID 4
4 · Biostage, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
GREEN DAVID
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-05-12$5.92/sh+63,345$375,002→ 158,861 total - Purchase
Warrants (right to buy)
2022-05-12+31,673→ 31,673 totalExercise: $8.88From: 2022-05-12Exp: 2027-05-12→ Common Stock (31,673 underlying)
Holdings
- 16,468(indirect: 2018 Biostage GRAT)
Common Stock
Footnotes (1)
- [F1]On May 12, 2022, the Issuer and the Reporting Person entered into 2 securities purchase agreements (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 63,345 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 31,673 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreements was $375,000.